Business Standard

Tuesday, December 24, 2024 | 01:06 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Madras HC orders formation of panel to ensure self-reliance in cancer drugs

In its judgment the court said India can not be dependent on China for APIs and ordered the formation of a five member committee to ensure self-reliance

Madras High Court
Premium

The judge pointed out how cheap imported APIs, had turned India from being a pioneer in generics and pharmacy to the world to a mere formulations’ hub.

T E Narasimhan Chennai
The Madras High Court's Justice N Kirubakaran has said that India has emerged as a pioneer in pharmaceuticals. Yet, for the basic ingredients of medicine making, it is heavily dependent on imports from China. This dependency handicaps us. It also makes our patients vulnerable if tensions escalate between the two countries. He also ordered formation of a 5-member committee to help bring foreign exchange for the country and to ensure India's self-reliance when it comes to cancer drugs.

In his 226-page order Justice Kirubakaran on a couple of writ petitions moved by Chennai-based Vinkem Labs, directed the constitution of a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in